Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys

Donna M. Platt, James K. Rowlett, Sari E Izenwasser, Roger D. Spealman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

3-O-Methylnaltrexone (3-MNTX), a putative antagonist of morphine-6-β-D-glucuronide (M6G) receptors, has been reported to block the behavioral effects of heroin at doses that do not block those of morphine, suggesting that M6G receptors may play a unique role in the addictive properties of heroin. This study investigated the effects of 3-MNTX in monkeys trained to discriminate i.v. heroin from vehicle or to self-administer i.v. heroin under a progressive-ratio schedule. Additional in vitro studies determined the effects of 3-MNTX and reference drugs on adenylyl cyclase activity in caudate-putamen membranes of monkeys and rats. In drug discrimination experiments, heroin, morphine, and M6G substituted for heroin in all subjects, whereas 3-MNTX substituted for heroin in one-half the monkeys tested. In these latter monkeys, the effects of 3-MNTX were antagonized by naltrexone, and pretreatment with 3-MNTX enhanced the effects of heroin, M6G, and morphine, indicative of μ-agonist activity. In monkeys showing no substitution of 3-MNTX for heroin, 3-MNTX antagonized the effects of heroin, M6G, and morphine. In self-administration experiments, heroin and 3-MNTX maintained injections per session significantly above those maintained by vehicle when the initial response requirement (IRR) was low; only heroin maintained significant self-administration when the IRR was high. In vitro, 3-MNTX inhibited adenylyl cyclase activity in both monkey and rat brain membranes. The degree of inhibition produced by 3-MNTX was less than that produced by the full agonist [D-Ala2,N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO). The results suggest that 3-MNTX functions primarily as a partial agonist at μ-receptors in monkeys and do not support a singular role for M6G receptors in the abuse-related effects of heroin.

Original languageEnglish
Pages (from-to)1030-1039
Number of pages10
JournalJournal of Pharmacology and Experimental Therapeutics
Volume308
Issue number3
DOIs
StatePublished - Mar 1 2004

Fingerprint

Heroin
Macaca mulatta
Opioid Analgesics
Haplorhini
Morphine
Self Administration
Adenylyl Cyclases
methylnaltrexone
Naltrexone
Membranes
Enkephalins
Putamen
Pharmaceutical Preparations
morphine-6-glucuronide
Appointments and Schedules

ASJC Scopus subject areas

  • Pharmacology

Cite this

Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys. / Platt, Donna M.; Rowlett, James K.; Izenwasser, Sari E; Spealman, Roger D.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 308, No. 3, 01.03.2004, p. 1030-1039.

Research output: Contribution to journalArticle

Platt, Donna M. ; Rowlett, James K. ; Izenwasser, Sari E ; Spealman, Roger D. / Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys. In: Journal of Pharmacology and Experimental Therapeutics. 2004 ; Vol. 308, No. 3. pp. 1030-1039.
@article{c71827190fe4429bb79cb71932ab3747,
title = "Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys",
abstract = "3-O-Methylnaltrexone (3-MNTX), a putative antagonist of morphine-6-β-D-glucuronide (M6G) receptors, has been reported to block the behavioral effects of heroin at doses that do not block those of morphine, suggesting that M6G receptors may play a unique role in the addictive properties of heroin. This study investigated the effects of 3-MNTX in monkeys trained to discriminate i.v. heroin from vehicle or to self-administer i.v. heroin under a progressive-ratio schedule. Additional in vitro studies determined the effects of 3-MNTX and reference drugs on adenylyl cyclase activity in caudate-putamen membranes of monkeys and rats. In drug discrimination experiments, heroin, morphine, and M6G substituted for heroin in all subjects, whereas 3-MNTX substituted for heroin in one-half the monkeys tested. In these latter monkeys, the effects of 3-MNTX were antagonized by naltrexone, and pretreatment with 3-MNTX enhanced the effects of heroin, M6G, and morphine, indicative of μ-agonist activity. In monkeys showing no substitution of 3-MNTX for heroin, 3-MNTX antagonized the effects of heroin, M6G, and morphine. In self-administration experiments, heroin and 3-MNTX maintained injections per session significantly above those maintained by vehicle when the initial response requirement (IRR) was low; only heroin maintained significant self-administration when the IRR was high. In vitro, 3-MNTX inhibited adenylyl cyclase activity in both monkey and rat brain membranes. The degree of inhibition produced by 3-MNTX was less than that produced by the full agonist [D-Ala2,N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO). The results suggest that 3-MNTX functions primarily as a partial agonist at μ-receptors in monkeys and do not support a singular role for M6G receptors in the abuse-related effects of heroin.",
author = "Platt, {Donna M.} and Rowlett, {James K.} and Izenwasser, {Sari E} and Spealman, {Roger D.}",
year = "2004",
month = "3",
day = "1",
doi = "10.1124/jpet.103.060962",
language = "English",
volume = "308",
pages = "1030--1039",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys

AU - Platt, Donna M.

AU - Rowlett, James K.

AU - Izenwasser, Sari E

AU - Spealman, Roger D.

PY - 2004/3/1

Y1 - 2004/3/1

N2 - 3-O-Methylnaltrexone (3-MNTX), a putative antagonist of morphine-6-β-D-glucuronide (M6G) receptors, has been reported to block the behavioral effects of heroin at doses that do not block those of morphine, suggesting that M6G receptors may play a unique role in the addictive properties of heroin. This study investigated the effects of 3-MNTX in monkeys trained to discriminate i.v. heroin from vehicle or to self-administer i.v. heroin under a progressive-ratio schedule. Additional in vitro studies determined the effects of 3-MNTX and reference drugs on adenylyl cyclase activity in caudate-putamen membranes of monkeys and rats. In drug discrimination experiments, heroin, morphine, and M6G substituted for heroin in all subjects, whereas 3-MNTX substituted for heroin in one-half the monkeys tested. In these latter monkeys, the effects of 3-MNTX were antagonized by naltrexone, and pretreatment with 3-MNTX enhanced the effects of heroin, M6G, and morphine, indicative of μ-agonist activity. In monkeys showing no substitution of 3-MNTX for heroin, 3-MNTX antagonized the effects of heroin, M6G, and morphine. In self-administration experiments, heroin and 3-MNTX maintained injections per session significantly above those maintained by vehicle when the initial response requirement (IRR) was low; only heroin maintained significant self-administration when the IRR was high. In vitro, 3-MNTX inhibited adenylyl cyclase activity in both monkey and rat brain membranes. The degree of inhibition produced by 3-MNTX was less than that produced by the full agonist [D-Ala2,N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO). The results suggest that 3-MNTX functions primarily as a partial agonist at μ-receptors in monkeys and do not support a singular role for M6G receptors in the abuse-related effects of heroin.

AB - 3-O-Methylnaltrexone (3-MNTX), a putative antagonist of morphine-6-β-D-glucuronide (M6G) receptors, has been reported to block the behavioral effects of heroin at doses that do not block those of morphine, suggesting that M6G receptors may play a unique role in the addictive properties of heroin. This study investigated the effects of 3-MNTX in monkeys trained to discriminate i.v. heroin from vehicle or to self-administer i.v. heroin under a progressive-ratio schedule. Additional in vitro studies determined the effects of 3-MNTX and reference drugs on adenylyl cyclase activity in caudate-putamen membranes of monkeys and rats. In drug discrimination experiments, heroin, morphine, and M6G substituted for heroin in all subjects, whereas 3-MNTX substituted for heroin in one-half the monkeys tested. In these latter monkeys, the effects of 3-MNTX were antagonized by naltrexone, and pretreatment with 3-MNTX enhanced the effects of heroin, M6G, and morphine, indicative of μ-agonist activity. In monkeys showing no substitution of 3-MNTX for heroin, 3-MNTX antagonized the effects of heroin, M6G, and morphine. In self-administration experiments, heroin and 3-MNTX maintained injections per session significantly above those maintained by vehicle when the initial response requirement (IRR) was low; only heroin maintained significant self-administration when the IRR was high. In vitro, 3-MNTX inhibited adenylyl cyclase activity in both monkey and rat brain membranes. The degree of inhibition produced by 3-MNTX was less than that produced by the full agonist [D-Ala2,N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO). The results suggest that 3-MNTX functions primarily as a partial agonist at μ-receptors in monkeys and do not support a singular role for M6G receptors in the abuse-related effects of heroin.

UR - http://www.scopus.com/inward/record.url?scp=1342344543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342344543&partnerID=8YFLogxK

U2 - 10.1124/jpet.103.060962

DO - 10.1124/jpet.103.060962

M3 - Article

C2 - 14634035

AN - SCOPUS:1342344543

VL - 308

SP - 1030

EP - 1039

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -